LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,335,846 | -17.2% | 75,194 | -29.8% | 0.00% | 0.0% |
Q4 2023 | $7,655,367 | +0.7% | 107,188 | +1.6% | 0.00% | -50.0% |
Q2 2023 | $7,604,892 | -21.8% | 105,477 | -20.2% | 0.00% | 0.0% |
Q1 2023 | $9,722,940 | +0.3% | 132,177 | -8.9% | 0.00% | 0.0% |
Q4 2022 | $9,690,476 | -11.6% | 145,067 | +14.0% | 0.00% | -33.3% |
Q3 2022 | $10,958,961 | +0.9% | 127,267 | +4.5% | 0.00% | 0.0% |
Q2 2022 | $10,864,587 | -23.4% | 121,773 | -3.4% | 0.00% | 0.0% |
Q1 2022 | $14,182,852 | -25.0% | 126,081 | +3.0% | 0.00% | -25.0% |
Q4 2021 | $18,915,000 | +41.7% | 122,456 | +27.8% | 0.00% | +33.3% |
Q3 2021 | $13,345,000 | +86.6% | 95,790 | +75.7% | 0.00% | +50.0% |
Q2 2021 | $7,152,000 | -59.2% | 54,513 | -52.6% | 0.00% | -50.0% |
Q1 2021 | $17,546,000 | +31.0% | 115,091 | -14.6% | 0.00% | +33.3% |
Q4 2020 | $13,396,000 | +3.7% | 134,704 | -0.6% | 0.00% | 0.0% |
Q3 2020 | $12,922,000 | -36.8% | 135,563 | -25.8% | 0.00% | -50.0% |
Q2 2020 | $20,444,000 | +32.3% | 182,782 | -14.0% | 0.01% | 0.0% |
Q1 2020 | $15,452,000 | -34.7% | 212,481 | -6.3% | 0.01% | -14.3% |
Q4 2019 | $23,646,000 | +0.8% | 226,729 | -3.8% | 0.01% | 0.0% |
Q3 2019 | $23,465,000 | -12.8% | 235,737 | 0.0% | 0.01% | -12.5% |
Q2 2019 | $26,910,000 | -9.2% | 235,737 | 0.0% | 0.01% | -20.0% |
Q1 2019 | $29,635,000 | -7.4% | 235,737 | 0.0% | 0.01% | -16.7% |
Q4 2018 | $31,990,000 | -47.7% | 235,737 | +5.8% | 0.01% | -40.0% |
Q3 2018 | $61,135,000 | +41.6% | 222,721 | +6.8% | 0.02% | +33.3% |
Q2 2018 | $43,184,000 | +33.4% | 208,449 | +6.3% | 0.02% | +25.0% |
Q1 2018 | $32,374,000 | +34.2% | 196,017 | +11.3% | 0.01% | +33.3% |
Q4 2017 | $24,116,000 | +12.4% | 176,117 | +11.8% | 0.01% | +12.5% |
Q3 2017 | $21,452,000 | +12.1% | 157,565 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $19,128,000 | +17.3% | 157,565 | +2.3% | 0.01% | +14.3% |
Q1 2017 | $16,301,000 | -16.4% | 154,014 | -19.7% | 0.01% | -22.2% |
Q4 2016 | $19,500,000 | +4.2% | 191,907 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $18,707,000 | -12.2% | 191,907 | +7.5% | 0.01% | -10.0% |
Q2 2016 | $21,297,000 | +29.0% | 178,565 | +15.8% | 0.01% | +25.0% |
Q1 2016 | $16,510,000 | -1.2% | 154,165 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $16,715,000 | +26.6% | 154,165 | 0.0% | 0.01% | +14.3% |
Q3 2015 | $13,204,000 | +109.7% | 154,165 | +147.0% | 0.01% | +133.3% |
Q2 2015 | $6,298,000 | +111.9% | 62,417 | +61.9% | 0.00% | +200.0% |
Q1 2015 | $2,972,000 | +44.9% | 38,543 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,051,000 | – | 38,543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |